New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS
4/17/2012 9:41:30 AM
More...
|
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines
12/20/2011 8:51:33 AM
More...
|
Mentor Capital Takes Investment Position in Each of 10 Cancer Immunotherapy Index Companies
1/19/2010 9:20:01 AM
More...
|
Antigenics Inc. (New York) (AGEN) Receives NASDAQ Delisting Notification
1/4/2010 9:21:03 AM
More...
|
Antigenics Inc. (New York) (AGEN) Cancer Vaccine Gets Negative EU Panel Vote
11/20/2009 8:24:27 AM
More...
|
Antigenics Inc. (New York) (AGEN) Buoyed by Brain-Cancer Study
10/26/2009 8:03:13 AM
More...
|
Antigenics Inc. (New York) (AGEN) to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow
10/22/2009 9:40:32 AM
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement
8/4/2009 7:37:57 AM
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement
7/31/2009 8:28:34 AM
More...
|
Antigenics Inc. (New York) (AGEN) to Report Second Quarter 2009 Financial Results on July 30 2009; Conference Call to Follow
7/23/2009 9:46:57 AM
More...
|
|